Hormone Replacement Therapy to Tackle MASLD Progression in Peri-Menopausal Women: Window of Opportunity or Call for Precision?

Liver Int. 2026 Apr;46(4):e70616. doi: 10.1111/liv.70616.

Authors

Lanlan Chen^{1

2}, Frank Tacke¹

Affiliations

¹ Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany.
² Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, the First Hospital of Jilin University, Changchun, China.

PMID: 41883105
DOI: 10.1111/liv.70616

No abstract available

Publication types

Editorial

Grants and funding